These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38569055)

  • 1. Association Between Treatment Adherence and Continuous Glucose Monitoring Outcomes in People With Diabetes Using Smart Insulin Pens in a Real-World Setting.
    Danne TPA; Joubert M; Hartvig NV; Kaas A; Knudsen NN; Mader JK
    Diabetes Care; 2024 Jun; 47(6):995-1003. PubMed ID: 38569055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart Pen Exposes Missed Basal Insulin Injections and Reveals the Impact on Glycemic Control in Adults With Type 1 Diabetes.
    Ekberg NR; Hartvig NV; Kaas A; Møller JB; Adolfsson P
    J Diabetes Sci Technol; 2024 Jan; 18(1):66-73. PubMed ID: 35775735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes.
    Hellman J; Hartvig NV; Kaas A; Møller JB; Sørensen MR; Jendle J
    Diabetes Obes Metab; 2024 Jan; 26(1):301-310. PubMed ID: 37926903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen.
    Adolfsson P; Hartvig NV; Kaas A; Møller JB; Hellman J
    Diabetes Technol Ther; 2020 Oct; 22(10):709-718. PubMed ID: 32003590
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal Insulins.
    De Groote R; Lefever E; Charleer S; Donné P; Block C; Mathieu C; Gillard P
    Diabetes Technol Ther; 2024 Aug; 26(8):587-595. PubMed ID: 38512387
    [No Abstract]   [Full Text] [Related]  

  • 6. Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen.
    MacLeod J; Im GH; Smith M; Vigersky RA
    Diabetes Technol Ther; 2024 Jan; 26(1):33-39. PubMed ID: 37855818
    [No Abstract]   [Full Text] [Related]  

  • 7. Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach.
    El Fathi A; Fabris C; Breton MD
    Front Endocrinol (Lausanne); 2021; 12():795895. PubMed ID: 35082757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the Relationship Between Pre- and Postprandial Glucose Levels and Insulin Bolus Timing Using Bluetooth-Enabled Insulin Pen Cap Technology and Continuous Glucose Monitoring.
    Toschi E; Slyne C; Greenberg JM; Greaves T; Atakov-Castillo A; Carl S; Dufour AB; Munshi M
    Diabetes Technol Ther; 2020 Jan; 22(1):19-24. PubMed ID: 31483167
    [No Abstract]   [Full Text] [Related]  

  • 9. The Effect of high temperature on the stability of basal insulin in a pen: a randomized controlled, crossover, equivalence trial.
    Kongmalai T; Orarachin P; Dechates B; Chanphibun P; Junnu S; Srisawat C; Sriwijitkamol A
    BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36585035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy.
    Schaupp L; Donsa K; Neubauer KM; Mader JK; Aberer F; Höll B; Spat S; Augustin T; Beck P; Pieber TR; Plank J
    Diabetes Technol Ther; 2015 Sep; 17(9):611-8. PubMed ID: 25927357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin degludec requires lower bolus insulin doses than does insulin glargine in Japanese diabetic patients with insulin-dependent state.
    Komuro M; Inoue G; Tabata M; Yamada Y; Atsuda K; Matsubara H; Irie J; Uchida J; Nakajima C; Izumi H; Shimada M; Yamada S
    J Diabetes Sci Technol; 2015 May; 9(3):632-8. PubMed ID: 25526758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-term effects of insulin degludec on patients with type 1 diabetes mellitus.
    Nakae R; Kusunoki Y; Katsuno T; Tokuda M; Akagami T; Murai K; Hamaguchi T; Miyagawa J; Namba M
    Drugs R D; 2014 Jun; 14(2):133-8. PubMed ID: 24838615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study.
    Galasso S; Facchinetti A; Bonora BM; Mariano V; Boscari F; Cipponeri E; Maran A; Avogaro A; Fadini GP; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1112-1119. PubMed ID: 27618501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Glucose Monitoring and Bolus Calculators: A Good Combination.
    Heinemann L; Thomas A
    J Diabetes Sci Technol; 2024 Jul; 18(4):761-763. PubMed ID: 37804180
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients.
    Mader JK; Neubauer KM; Schaupp L; Augustin T; Beck P; Spat S; Höll B; Treiber GM; Fruhwald FM; Pieber TR; Plank J
    Diabetes Obes Metab; 2014 Feb; 16(2):137-46. PubMed ID: 23910952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemia observed during continuous glucose monitoring in patients with type 2 diabetes mellitus treated by subcutaneous insulin injection.
    Ito H; Abe M; Shinozaki M; Oshikiri K; Yamashita H; Nakashima M; Takaki A; Yukawa C; Furusho M; Antoku S; Mifune M; Togane M
    Diabetes Technol Ther; 2013 Jul; 15(7):586-90. PubMed ID: 23578166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes.
    Edwards S; He X; Wang W; Poon JL; Meadows E; Price D; Johnson J; Wolpert H; Polonsky W
    Diabetes Technol Ther; 2022 Jan; 24(1):61-66. PubMed ID: 34524010
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles.
    Bergenstal RM; Johnson ML; Aroda VR; Brazg RL; Dreon DM; Frias JP; Kruger DF; Molitch ME; Mullen DM; Peyrot M; Richter S; Rosenstock J; Serusclat P; Vance C; Weinstock RS; Levy BL
    J Diabetes Sci Technol; 2022 Sep; 16(5):1167-1173. PubMed ID: 34008442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.